MicroRNA-132 promotes fibroblast migration via regulating RAS p21 protein activator 1 in skin wound healing. 2017

Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

MicroRNA (miR)-132 has been identified as a top up-regulated miRNA during skin wound healing and its inhibition impairs wound repair. In a human in vivo surgical wound model, we showed that miR-132 was induced in epidermal as well as in dermal wound-edge compartments during healing. Moreover, in a panel of cells isolated from human skin wounds, miR-132 was found highly expressed in human dermal fibroblasts (HDFs). In HDFs, miR-132 expression was upregulated by TGF-β1. By overexpression or inhibition of miR-132, we showed that miR-132 promoted HDF migration. Mechanistically, global transcriptome analysis revealed that RAS signaling pathway was regulated by miR-132 in HDFs. We found that RAS p21 protein activator 1 (RASA1), a known target of miR-132, was downregulated in HDFs upon miR-132 overexpression. Silencing of RASA1 phenocopied the pro-migratory effect of miR-132. Collectively, our study reveals an important role for miR-132 in HDFs during wound healing and indicates a therapeutic potential of miR-132 in hard-to-heal skin wounds.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072836 Surgical Wound An incision made during a surgical procedure. Surgical Incision,Incision, Surgical,Incisions, Surgical,Surgical Incisions,Surgical Wounds,Wound, Surgical,Wounds, Surgical
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D053773 Transforming Growth Factor beta1 A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME. TGF-beta1,Transforming Growth Factor-beta1,TGF-beta-1,TGF-beta1 Latency-Associated Protein,TGF-beta1LAP,Transforming Growth Factor beta 1 Latency Associated Peptide,Transforming Growth Factor beta I,Latency-Associated Protein, TGF-beta1,TGF beta 1,TGF beta1 Latency Associated Protein,TGF beta1LAP

Related Publications

Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
May 2018, Biochemical and biophysical research communications,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
January 2014, PloS one,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
August 2012, International wound journal,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
February 2024, Cell division,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
December 2023, Journal of cellular physiology,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
November 2001, The American journal of pathology,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
August 2010, PloS one,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
October 2021, Laboratory investigation; a journal of technical methods and pathology,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
September 2014, Cell transplantation,
Xi Li, and Dongqing Li, and Jakob D Wikstrom, and Andor Pivarcsi, and Enikö Sonkoly, and Mona Ståhle, and Ning Xu Landén
July 1997, The Journal of investigative dermatology,
Copied contents to your clipboard!